0001209191-22-007887.txt : 20220208
0001209191-22-007887.hdr.sgml : 20220208
20220208202356
ACCESSION NUMBER: 0001209191-22-007887
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220207
FILED AS OF DATE: 20220208
DATE AS OF CHANGE: 20220208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARCIA PETER S
CENTRAL INDEX KEY: 0001188956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 22603475
MAIL ADDRESS:
STREET 1: ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-07
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001188956
GARCIA PETER S
C/O ALX ONCOLOGY HOLDINGS INC.
866 MALCOLM ROAD, SUITE 100
BURLINGAME
CA
94010
0
1
0
0
Chief Financial Officer
Common Stock
2022-02-07
4
M
0
6637
4.08
A
16120
D
Common Stock
2022-02-07
4
M
0
8363
4.81
A
24483
D
Employee Stock Option (right to buy)
4.08
2022-02-07
4
M
0
6637
0.00
D
2030-03-09
Common Stock
6637
89022
D
Employee Stock Option (right to buy)
4.08
2030-03-09
Common Stock
60468
60468
D
Employee Stock Option (right to buy)
4.81
2022-02-07
4
M
0
8363
0.00
D
2030-04-27
Common Stock
8363
20813
D
Includes 152 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021.
The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter.
The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter.
One-fourth of the shares subject to the option vest on April 27, 2021 and 1/36th of the remaining shares vest monthly thereafter.
/s/ Peter Garcia
2022-02-08